Xultophy 100/3.6 (insulin degludec and liraglutide) injection is now available as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes inadequately controlled on basal insulin (<50 units daily) or liraglutide (≤1.8mg daily).